Drugs / HTX-009
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02762929 | May 2016 → Feb 2017 | — | Heron Therapeutics | Completed | No outcome recorded |
| Phase 2 | NCT02504580 | Jul 2015 → Mar 2017 | — | Heron Therapeutics | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HTX-009 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02504580 ↗ |
| Route | Other | “HTX-009 by injection and instillation (combination).” NCT02504580 ↗ |